As of 2024, the estimated number of cardiologists employed in the United States ranged from ** cardiologists to around ***** by state. New York registered the highest number of cardiologists, whereas North Dakota and West Virginia had the lowest.

As of April 2025, there were a total of 570,655 specialty physicians active in the United States. Of these, most were specialized in emergency medicine. Physician compensation Significant pay variations exist across specialties and regions, with orthopedic doctors and surgeons command the highest average annual salaries at 564,000 U.S. dollars. Meanwhile, the Midwest region offers the highest average physician compensation at 385,000 U.S. dollars annually. Interestingly, doctors in Northern parts of the United States tend to earn less than their counterparts in other regions. Burnout among physicians Despite high salaries, U.S. physicians face high workload and stress in the workplace. Nearly half of surveyed doctors reported feeling burnout, with higher burnout rates among female doctors, younger physicians, and those in primary care compared to their counterparts. More effort to combat burnout is needed in the healthcare system. Increasing compensation was cited by physicians as the top measure to alleviate burnout, followed by adding support staff and offering more flexible schedules.

Number of Businesses statistics on the Cardiologists industry in the US

Comprehensive dataset of 94,687 Cardiologists in United States as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Employment statistics on the Cardiologists industry in the US

Comprehensive dataset containing 119 verified Pediatric cardiologist businesses in Indiana, United States with complete contact information, ratings, reviews, and location data.

Economic factors quickly supported funding for pent-up demand for cardiologist services, which the pandemic temporarily suppressed. Rising per capita disposable income, increased government funding for Medicare and Medicaid and modest growth in the number of individuals with private health insurance bolstered reimbursements and payments to cardiologists. Also, the aging population and new demand from long COVID cases positively influenced the need for services. With public health campaigns (CDC) focused on heart health during the pandemic and after spurring awareness and advocating preventative measures, industry revenue is projected to grow at a CAGR of 1.3%, reaching $59.6 billion in 2024, with a slight gain of 0.1% in 2024 alone and profit anticipated to be 14.8% of revenue. The cardiology sector is being reshaped through mergers and consolidation. Increasingly, cardiologists are joining large, multispecialty practices drawn by the benefits of collaborative care. These larger groups offer access to advanced technology and superior patient management systems, which enhance financial stability. Larger practices also wield more negotiating power with large insurance companies and are better positioned to handle the challenges of value-based payment systems. Medicaid and Medicare are moving toward these systems, which incentivize cardiologists based on the effectiveness of their care. Looking ahead to the next five years, AI-powered diagnostic tools and telemedicine platforms are set to expand cardiologists' reach beyond geographical limitations, increasing patient volumes and potentially boosting revenue. However, integrating AI poses challenges, including ethical concerns and regulatory hurdles. Widespread adoption of AI and telemedicine will heighten competition, giving early adopters an edge. Nonetheless, demand for services for both new entrants and smaller cardiology practitioners will be strong because of an aging population and the persistent effects of long COVID, amplifying the need for specialized care, particularly in underserved areas. In the dynamic marketplace, characterized by increasing competition, innovation and consolidation, industry revenue is forecast to grow at a CAGR of 3.2%, reaching $69.8 billion by 2029.

This statistic shows the total number of doctors of medicine in the United States from 1949 to 2015. In 1949, there were ******* doctors of medicine in the United States. Some 50 years later, the number was around **** times as high. In 2015, the exact number of doctors of medicine was *********.

Comprehensive dataset of 1,723 Cardiologists in Maryland, United States as of August, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset containing 191 verified Pediatric cardiologist businesses in Kentucky, United States with complete contact information, ratings, reviews, and location data.

Comprehensive dataset of 410 Pediatric cardiologists in Illinois, United States as of August, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

In 2025, it took on average 32.7 days to get a non-urgent cardiology appointment (such as a heart check-up) in the United States. This was according to a survey of physicians offices in 15 major U.S. metropolitan areas. Wait time has increased from half a month in 2009.

Comprehensive dataset of 14 Pediatric cardiologists in Alaska, United States as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

As of May 2024, there were a total of 15,527 active specialty physicians in the U.S. state of Georgia. This included some 1,355 psychiatrists and 639 oncologists.

Comprehensive dataset of 149 Pediatric cardiologists in Arizona, United States as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Rotational Atherectomy Systems Market Outlook

According to our latest research, the global rotational atherectomy systems market size was valued at USD 1.14 billion in 2024. The market is projected to expand at a CAGR of 6.8% over the forecast period, reaching USD 2.09 billion by 2033. The primary growth factor driving this robust expansion is the rising global burden of cardiovascular diseases, particularly coronary and peripheral artery diseases, which necessitate advanced interventional procedures. As per the latest research, technological advancements in atherectomy devices and heightened awareness regarding minimally invasive procedures are further accelerating market adoption.

A major growth driver for the rotational atherectomy systems market is the increasing prevalence of atherosclerotic cardiovascular diseases worldwide. With sedentary lifestyles, unhealthy dietary habits, and an aging population, the incidence of arterial blockages has surged, especially in developed and emerging economies. This has led to a corresponding increase in demand for interventional cardiology procedures, where rotational atherectomy systems are vital for treating complex calcified lesions. Moreover, the growing number of interventional cardiologists and the expansion of catheterization laboratories in hospitals are making these procedures more accessible, thereby boosting the adoption of rotational atherectomy systems. Additionally, rising patient awareness about the benefits of minimally invasive techniques, such as reduced hospital stays and faster recovery times, is driving patient preference toward these advanced interventions.

Technological innovation is another pivotal factor propelling the rotational atherectomy systems market forward. Leading manufacturers are investing significantly in research and development to enhance device efficacy, safety, and user-friendliness. Key advancements include the integration of improved burr designs, enhanced rotational speeds, and real-time imaging capabilities, all of which contribute to better clinical outcomes. The introduction of single-use atherectomy systems has also addressed critical concerns related to cross-contamination and device-associated infections, further encouraging adoption. These technological strides are not only improving procedural efficiency but are also broadening the scope of atherectomy applications, making it feasible to treat a wider range of arterial lesions and patient profiles.

The increasing focus on healthcare infrastructure development, particularly in emerging regions, is playing a significant role in market expansion. Governments and private healthcare providers are investing in the modernization of hospitals and ambulatory surgical centers, equipping them with advanced interventional cardiology devices. This, coupled with favorable reimbursement policies in key markets such as North America and Europe, is facilitating greater patient access to rotational atherectomy procedures. Furthermore, collaborative efforts between device manufacturers and healthcare institutions to provide training and education for healthcare professionals are enhancing procedural expertise, thus raising the standard of care and further fueling market growth.

Regionally, North America currently dominates the rotational atherectomy systems market, accounting for the largest revenue share in 2024, followed by Europe and the Asia Pacific. The United States, in particular, benefits from high healthcare expenditure, a well-established healthcare infrastructure, and a large pool of skilled interventional cardiologists. Europe is witnessing steady growth due to increasing cardiovascular disease prevalence and supportive regulatory frameworks. Meanwhile, the Asia Pacific region is emerging as a lucrative market, driven by rising healthcare investments, expanding medical tourism, and improving access to advanced cardiovascular treatments. Latin America and the Middle East & Africa, while smaller in market size, are expected to witness accelerated growth rates as healthcare systems continue to evolve and awareness levels rise.

Comprehensive dataset containing 101 verified Pediatric cardiologist businesses in South Carolina, United States with complete contact information, ratings, reviews, and location data.

Comprehensive dataset containing 26 verified Pediatric cardiologist businesses in Kansas, United States with complete contact information, ratings, reviews, and location data.

Comprehensive dataset containing 37 verified Pediatric cardiologist businesses in Iowa, United States with complete contact information, ratings, reviews, and location data.

IVL System Market Outlook

According to the latest research conducted in 2025, the global IVL System market size is valued at USD 1.32 billion in 2024, with a robust compound annual growth rate (CAGR) of 15.7% expected from 2025 to 2033. By the end of 2033, the market is forecasted to reach approximately USD 4.85 billion. This significant growth trajectory is primarily driven by the increasing prevalence of cardiovascular diseases worldwide, coupled with advancements in minimally invasive treatment technologies. The expanding geriatric population, rising awareness about intravascular lithotripsy (IVL) systems, and growing investments in healthcare infrastructure are further fueling the adoption of IVL systems across diverse healthcare settings.

One of the key growth factors propelling the IVL System market is the rising global burden of calcified arterial diseases, including both coronary artery disease and peripheral artery disease. These conditions often require advanced interventional solutions when conventional angioplasty or atherectomy techniques are insufficient. IVL systems, which utilize sonic pressure waves to fracture vascular calcium, offer a safer and more effective alternative for treating heavily calcified lesions. The clinical benefits, such as reduced procedural complications and enhanced stent delivery, are driving their adoption among interventional cardiologists and vascular surgeons. Additionally, the increasing number of clinical studies demonstrating favorable outcomes and regulatory approvals for new IVL devices are accelerating market penetration.

Another significant driver is the technological innovation within the IVL system landscape. Manufacturers are consistently investing in research and development to enhance device efficacy, safety, and ease of use. The introduction of next-generation balloon-based and catheter-based IVL systems with improved deliverability and real-time imaging capabilities is transforming the treatment paradigm for complex vascular lesions. Furthermore, the integration of IVL technology with digital health platforms and artificial intelligence for real-time procedural guidance is expected to further optimize clinical outcomes and workflow efficiency. These advancements are contributing to greater physician confidence and expanding the application scope of IVL systems beyond traditional indications.

The IVL System market is also benefiting from favorable reimbursement policies and increased healthcare spending, particularly in developed regions such as North America and Europe. Governments and private insurers are recognizing the long-term benefits of IVL procedures in reducing hospital readmissions and improving patient quality of life. This, in turn, is encouraging hospitals, specialty clinics, and ambulatory surgical centers to invest in advanced IVL technologies. Additionally, the growing trend of outpatient and minimally invasive procedures is supporting the adoption of IVL systems in ambulatory settings, further broadening the market base.

Regionally, North America dominates the global IVL System market, accounting for the largest revenue share in 2024, followed by Europe and Asia Pacific. The United States, in particular, is at the forefront due to its high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and early adoption of innovative medical devices. Europe is witnessing steady growth driven by supportive regulatory frameworks and increasing awareness about minimally invasive interventions. Meanwhile, Asia Pacific is emerging as a lucrative market, supported by rising healthcare investments, expanding patient pool, and ongoing medical device commercialization efforts in countries like China, Japan, and India. Latin America and the Middle East & Africa are also experiencing gradual adoption, albeit at a slower pace due to limited healthcare resources and lower awareness levels.

Product Type Analysis

The IVL System market by product type is segmented into balloon-based IVL